<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35966226</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2673-6101</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in allergy</Title><ISOAbbreviation>Front Allergy</ISOAbbreviation></Journal><ArticleTitle>Neutrophil and Eosinophil Responses Remain Abnormal for Several Months in Primary Care Patients With COVID-19 Disease.</ArticleTitle><Pagination><StartPage>942699</StartPage><MedlinePgn>942699</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">942699</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/falgy.2022.942699</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Neutrophil and eosinophil activation and its relation to disease severity has been understudied in primary care patients with COVID-19. In this study, we investigated whether the neutrophil and eosinophil compartment were affected in primary care patients with COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">COVID-19 patients, aged &#x2265; 40 years with cardiovascular comorbidity presenting to the general practitioner with substantial symptoms, partaking in the COVIDSat@Home study between January and April 2021, were included. Blood was drawn during and 3 to 6 months after active COVID-19 disease and analyzed by automated flow cytometry, before and after stimulation with a formyl-peptide (fNLF). Mature neutrophil and eosinophil markers at both time points were compared to healthy controls. A questionnaire was conducted on disease symptoms during and 3 to 6 months after COVID-19 disease.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The blood of 18 COVID-19 patients and 34 healthy controls was analyzed. During active COVID-19 disease, neutrophils showed reduced CD10 (<i>p</i> = 0.0360), increased CD11b (<i>p</i> = 0.0002) and decreased CD62L expression (<i>p</i> &lt; 0.0001) compared to healthy controls. During active COVID-19 disease, fNLF stimulated neutrophils showed decreased CD10 levels (<i>p</i> &lt; 0.0001). Three to six months after COVID-19 disease, unstimulated neutrophils showed lowered CD62L expression (<i>p</i> = 0.0003) and stimulated neutrophils had decreased CD10 expression (<i>p</i> = 0.0483) compared to healthy controls. Both (un)stimulated CD10 levels increased 3 to 6 months after active disease (<i>p</i> = 0.0120 and <i>p</i> &lt; 0.0001, respectively) compared to during active disease. Eosinophil blood counts were reduced during active COVID-19 disease and increased 3 to 6 months after infection (<i>p</i> &lt; 0.0001). During active COVID-19, eosinophils showed increased unstimulated CD11b (<i>p</i> = 0.0139) and decreased (un)stimulated CD62L expression (<i>p</i> = 0.0036 and <i>p</i> = 0.0156, respectively) compared to healthy controls. Three to six months after COVID-19 disease, (un)stimulated eosinophil CD62L expression was decreased (<i>p</i> = 0.0148 and <i>p</i> = 0.0063, respectively) and the percentage of CD11b<sup>bright</sup> cells was increased (<i>p</i> = 0.0083 and <i>p</i> = 0.0307, respectively) compared to healthy controls.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Automated flow cytometry analysis reveals specific mature neutrophil and eosinophil activation patterns in primary care patients with COVID-19 disease, during and 3 to 6 months after active disease. This suggests that the neutrophil and eosinophil compartment are long-term affected by COVID-19 in primary care patients. This indicates that these compartments may be involved in the pathogenesis of long COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Jukema, Smit, Hopman, Bongers, Pelgrim, Rijk, Platteel, Venekamp, Zwart, Rutten and Koenderman.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jukema</LastName><ForeName>B N</ForeName><Initials>BN</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smit</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of General Practice, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hopman</LastName><ForeName>M T E</ForeName><Initials>MTE</Initials><AffiliationInfo><Affiliation>Department of Physiology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bongers</LastName><ForeName>C C W G</ForeName><Initials>CCWG</Initials><AffiliationInfo><Affiliation>Department of Physiology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelgrim</LastName><ForeName>T C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijk</LastName><ForeName>M H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of General Practice, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Platteel</LastName><ForeName>T N</ForeName><Initials>TN</Initials><AffiliationInfo><Affiliation>Department of General Practice, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venekamp</LastName><ForeName>R P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Department of General Practice, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zwart</LastName><ForeName>D L M</ForeName><Initials>DLM</Initials><AffiliationInfo><Affiliation>Department of General Practice, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rutten</LastName><ForeName>F H</ForeName><Initials>FH</Initials><AffiliationInfo><Affiliation>Department of General Practice, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koenderman</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Allergy</MedlineTA><NlmUniqueID>9918227355906676</NlmUniqueID><ISSNLinking>2673-6101</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">activation</Keyword><Keyword MajorTopicYN="N">flow cytometry</Keyword><Keyword MajorTopicYN="N">granulocytes</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">primary care</Keyword></KeywordList><CoiStatement>The AQUIOS CL&#xae; &#x201c;Load &amp; Go&#x201d; flow cytometer is provided by the company Beckman Coulter Life Sciences, Miami, FL, USA. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>15</Day><Hour>3</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35966226</ArticleId><ArticleId IdType="pmc">PMC9365032</ArticleId><ArticleId IdType="doi">10.3389/falgy.2022.942699</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S, et al. . A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect. (2021) 54:12&#x2013;6. 10.1016/j.jmii.2020.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.05.001</ArticleId><ArticleId IdType="pmc">PMC7227597</ArticleId><ArticleId IdType="pubmed">32425996</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Soleimani J, Herasevich S, Pinevich Y, Pennington KM, Dong Y, et al. . Clinical characteristics, treatment, and outcomes of critically ill patients with COVID-19: a scoping review. Mayo Clin Proc. (2021) 96:183&#x2013;202. 10.1016/j.mayocp.2020.10.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.10.022</ArticleId><ArticleId IdType="pmc">PMC7586927</ArticleId><ArticleId IdType="pubmed">33413817</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr. (2021) 15:869&#x2013;75. 10.1016/j.dsx.2021.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Spijkerman R, Bongers SH, Bindels BJJ, Tinnevelt GH, Giustarini G, Jorritsma NKN, et al. . Flow cytometric evaluation of the neutrophil compartment in COVID-19 at hospital presentation: a normal response to an abnormal situation. J Leukoc Biol. (2021) 109:99&#x2013;114. 10.1002/JLB.5COVA0820-520RRR</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.5COVA0820-520RRR</ArticleId><ArticleId IdType="pmc">PMC10016865</ArticleId><ArticleId IdType="pubmed">33617030</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalcante-Silva LHA, Carvalho DCM, Lima &#xc9; de A, Galv&#xe3;o JGFM, da Silva JS de F, Sales-Neto JM de, et al. . Neutrophils and COVID-19: The road so far. Int Immunopharmacol. (2021) 90:107233. 10.1016/j.intimp.2020.107233</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.107233</ArticleId><ArticleId IdType="pmc">PMC7703515</ArticleId><ArticleId IdType="pubmed">33290963</ArticleId></ArticleIdList></Reference><Reference><Citation>Reusch N, De Domenico E, Bonaguro L, Schulte-Schrepping J, Ba&#xdf;ler K, Schultze JL, et al. . Neutrophils in COVID-19. Front Immunol. (2021) 12:652470. 10.3389/fimmu.2021.652470</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.652470</ArticleId><ArticleId IdType="pmc">PMC8027077</ArticleId><ArticleId IdType="pubmed">33841435</ArticleId></ArticleIdList></Reference><Reference><Citation>Veras FP, Pontelli MC, Silva CM, Toller-Kawahisa JE, de Lima M, Nascimento DC, et al. . SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med. (2020) 217:e20201129. 10.1084/jem.20201129</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20201129</ArticleId><ArticleId IdType="pmc">PMC7488868</ArticleId><ArticleId IdType="pubmed">32926098</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanni F, Akker E, Zaman MM, Figueroa N, Tharian B, Hupart KH. Eosinopenia and COVID-19. J Am Osteopath Assoc. (2020). 120:504&#x2013;8. 10.7556/jaoa.2020.091</Citation><ArticleIdList><ArticleId IdType="doi">10.7556/jaoa.2020.091</ArticleId><ArticleId IdType="pubmed">32672799</ArticleId></ArticleIdList></Reference><Reference><Citation>Koenderman L, Siemers MJ, van Aalst C, Bongers SH, Spijkerman R, Bindels BJJ, et al. . The systemic immune response in COVID-19 is associated with a shift to formyl-peptide unresponsive eosinophils. Cells. (2021) 10:1109. 10.3390/cells10051109</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10051109</ArticleId><ArticleId IdType="pmc">PMC8147959</ArticleId><ArticleId IdType="pubmed">34062964</ArticleId></ArticleIdList></Reference><Reference><Citation>Smit K. Nieuw onderzoek naar thuis zuurstofsaturatie meten bij COVID-19-pati&#xeb;nten. Huisarts Wet. (2021) 64:75&#x2013;75. 10.1007/s12445-021-1070-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12445-021-1070-x</ArticleId><ArticleId IdType="pmc">PMC7917523</ArticleId><ArticleId IdType="pubmed">33678819</ArticleId></ArticleIdList></Reference><Reference><Citation>Spijkerman R, Hesselink L, Hellebrekers P, Vrisekoop N, Hietbrink F, Leenen LPH, et al. . Automated flow cytometry enables high performance point-of-care analysis of leukocyte phenotypes. J Immunol Methods. (2019) 474:112646. 10.1016/j.jim.2019.112646</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jim.2019.112646</ArticleId><ArticleId IdType="pubmed">31419409</ArticleId></ArticleIdList></Reference><Reference><Citation>Grieshaber-Bouyer R, Nigrovic PA. Neutrophil heterogeneity as therapeutic opportunity in immune-mediated disease. Front Immunol. (2019) 10:346. 10.3389/fimmu.2019.00346</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00346</ArticleId><ArticleId IdType="pmc">PMC6409342</ArticleId><ArticleId IdType="pubmed">30886615</ArticleId></ArticleIdList></Reference><Reference><Citation>Ota K, Shimizu Y, Ichikawa H, Ueda M, Akiyama N, Higuchi C, et al. . Neutrophil activation in immunoadsorption. Ther Apher. (2000) 4:229&#x2013;34. 10.1046/j.1526-0968.2000.00191.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1526-0968.2000.00191.x</ArticleId><ArticleId IdType="pubmed">10910025</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, et al. . Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care. (2020) 24:422. 10.1186/s13054-020-03120-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03120-0</ArticleId><ArticleId IdType="pmc">PMC7356137</ArticleId><ArticleId IdType="pubmed">32660650</ArticleId></ArticleIdList></Reference><Reference><Citation>Scialo F, Daniele A, Amato F, Pastore L, Matera MG, Cazzola M, et al. . ACE2: The major cell entry receptor for SARS-CoV-2. Lung. (2020) 198:867&#x2013;77. 10.1007/s00408-020-00408-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-020-00408-4</ArticleId><ArticleId IdType="pmc">PMC7653219</ArticleId><ArticleId IdType="pubmed">33170317</ArticleId></ArticleIdList></Reference><Reference><Citation>Elghetany MT. Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells Mol Dis. (2002) 28:260&#x2013;74. 10.1006/bcmd.2002.0513</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bcmd.2002.0513</ArticleId><ArticleId IdType="pubmed">12064921</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormack RT, Nelson RD, LeBien TW. Structure/function studies of the common acute lymphoblastic leukemia antigen (CALLA/CD10) expressed on human neutrophils. J Immunol. (1986) 137:1075&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">2941484</ArticleId></ArticleIdList></Reference><Reference><Citation>Cossman J, Neckers LM, Leonard WJ, Greene WC. Polymorphonuclear neutrophils express the common acute lymphoblastic leukemia antigen. J Exp Med. (1983) 157:1064&#x2013;9. 10.1084/jem.157.3.1064</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.157.3.1064</ArticleId><ArticleId IdType="pmc">PMC2186955</ArticleId><ArticleId IdType="pubmed">6220104</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf8;rvig S, &#xd8;stergaard O, Heegaard NHH, Borregaard N. Proteome profiling of human neutrophil granule subsets, secretory vesicles, and cell membrane: correlation with transcriptome profiling of neutrophil precursors. J Leukoc Biol. (2013) 94:711&#x2013;21. 10.1189/jlb.1212619</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.1212619</ArticleId><ArticleId IdType="pubmed">23650620</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Cabec V, Cowland JB, Calafat J, Borregaard N. Targeting of proteins to granule subsets is determined by timing and not by sorting: the specific granule protein NGAL is localized to azurophil granules when expressed in HL-60 cells. Proc Natl Acad Sci U S A. (1996) 93:6454&#x2013;7. 10.1073/pnas.93.13.6454</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.13.6454</ArticleId><ArticleId IdType="pmc">PMC39044</ArticleId><ArticleId IdType="pubmed">8692836</ArticleId></ArticleIdList></Reference><Reference><Citation>Borregaard N, Sehested M, Nielsen BS, Sengel&#xf8;v H, Kjeldsen L. Biosynthesis of granule proteins in normal human bone marrow cells. gelatinase is a marker of terminal neutrophil differentiation. Blood. (1995) 85:812&#x2013;7. 10.1182/blood.V85.3.812.bloodjournal853812</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V85.3.812.bloodjournal853812</ArticleId><ArticleId IdType="pubmed">7833481</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowland JB, Borregaard N. Granulopoiesis and granules of human neutrophils. Immunol Rev. (2016) 273:11&#x2013;28. 10.1111/imr.12440</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12440</ArticleId><ArticleId IdType="pubmed">27558325</ArticleId></ArticleIdList></Reference><Reference><Citation>Lominadze G, Powell DW, Luerman GC, Link AJ, Ward RA, McLeish KR. Proteomic analysis of human neutrophil granules. Mol Cell Proteomics. (2005) 4:1503&#x2013;21. 10.1074/mcp.M500143-MCP200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M500143-MCP200</ArticleId><ArticleId IdType="pubmed">15985654</ArticleId></ArticleIdList></Reference><Reference><Citation>Roca E, Ventura L, Zattra CM, Lombardi C, EOSINOPENIA . an early, effective and relevant COVID-19 biomarker? QJM. (2021) 114:68&#x2013;9. 10.1093/qjmed/hcaa259</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcaa259</ArticleId><ArticleId IdType="pmc">PMC7499754</ArticleId><ArticleId IdType="pubmed">32877511</ArticleId></ArticleIdList></Reference><Reference><Citation>Cazzaniga M, Fumagalli LAM, D'angelo L, Cerino M, Bonfanti G, Fumagalli RM, et al. . Eosinopenia is a reliable marker of severe disease and unfavourable outcome in patients with COVID-19 pneumonia. Int J Clin Pract. (2021) 75:e14047. 10.1111/ijcp.14047</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14047</ArticleId><ArticleId IdType="pmc">PMC7995195</ArticleId><ArticleId IdType="pubmed">33497517</ArticleId></ArticleIdList></Reference><Reference><Citation>Lourda M, Dzidic M, Hertwig L, Bergsten H, Palma Medina LM, Sinha I, et al. . High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19. Proc Natl Acad Sci U S A. (2021) 118:e2109123118. 10.1073/pnas.2109123118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2109123118</ArticleId><ArticleId IdType="pmc">PMC8501786</ArticleId><ArticleId IdType="pubmed">34548411</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesnil C, Raulier S, Paulissen G, Xiao X, Birrell MA, Pirottin D, et al. . Lung-resident eosinophils represent a distinct regulatory eosinophil subset. J Clin Invest. (2016) 126:3279&#x2013;95. 10.1172/JCI85664</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI85664</ArticleId><ArticleId IdType="pmc">PMC5004964</ArticleId><ArticleId IdType="pubmed">27548519</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez L, Pekkarinen PT, Lakshmikanth T, Tan Z, Consiglio CR, Pou C, et al. . Systems-level immunomonitoring from acute to recovery phase of severe COVID-19. Cell reports Med. (2020) 1:100078. 10.1016/j.xcrm.2020.100078</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2020.100078</ArticleId><ArticleId IdType="pmc">PMC7405891</ArticleId><ArticleId IdType="pubmed">32838342</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdanbakhsh M, Eckmann CM, Bot AA, Roos D. Bactericidal action of eosinophils from normal human blood. Infect Immun. (1986) 53:192&#x2013;8. 10.1128/iai.53.1.192-198.1986</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/iai.53.1.192-198.1986</ArticleId><ArticleId IdType="pmc">PMC260096</ArticleId><ArticleId IdType="pubmed">3522428</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg HF, Domachowske JB. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J Leukoc Biol. (2001) 70:691&#x2013;8. 10.1189/jlb.70.5.691</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.70.5.691</ArticleId><ArticleId IdType="pubmed">11698487</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores-Torres AS, Salinas-Carmona MC, Salinas E, Rosas-Taraco AG. Eosinophils and respiratory viruses. Viral Immunol. (2019) 32:198&#x2013;207. 10.1089/vim.2018.0150</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2018.0150</ArticleId><ArticleId IdType="pubmed">31140942</ArticleId></ArticleIdList></Reference><Reference><Citation>Spijkerman R, Hesselink L, Bongers S, van Wessem KJP, Vrisekoop N, Hietbrink F, et al. . Point-of-care analysis of neutrophil phenotypes: a first step toward immuno-based precision medicine in the trauma ICU. Crit care Explor. (2020) 2:e0158. 10.1097/CCE.0000000000000158</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000158</ArticleId><ArticleId IdType="pmc">PMC7371075</ArticleId><ArticleId IdType="pubmed">32766555</ArticleId></ArticleIdList></Reference><Reference><Citation>van Staveren S, Ten Haaf T, Kl&#xf6;pping M, Hilvering B, Tinnevelt GH, de Ruiter K, et al. . Multi-dimensional flow cytometry analysis reveals increasing changes in the systemic neutrophil compartment during seven consecutive days of endurance exercise. PLoS ONE. (2018) 13:e0206175. 10.1371/journal.pone.0206175</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0206175</ArticleId><ArticleId IdType="pmc">PMC6207321</ArticleId><ArticleId IdType="pubmed">30376575</ArticleId></ArticleIdList></Reference><Reference><Citation>Bongers SH, Chen N, van Grinsven E, van Staveren S, Hassani M, Spijkerman R, et al. . Kinetics of neutrophil subsets in acute, subacute, and chronic inflammation. Front Immunol. (2021) 12:674079. 10.3389/fimmu.2021.674079</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.674079</ArticleId><ArticleId IdType="pmc">PMC8265311</ArticleId><ArticleId IdType="pubmed">34248955</ArticleId></ArticleIdList></Reference><Reference><Citation>Tak T, Wijten P, Heeres M, Pickkers P, Scholten A, Heck AJR, et al. . Human CD62Ldim neutrophils identified as a separate subset by proteome profiling and in vivo pulse-chase labeling. Blood. (2017) 129:3476&#x2013;85. 10.1182/blood-2016-07-727669</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2016-07-727669</ArticleId><ArticleId IdType="pubmed">28515092</ArticleId></ArticleIdList></Reference><Reference><Citation>Leliefeld PHC, Pillay J, Vrisekoop N, Heeres M, Tak T, Kox M, et al. . Differential antibacterial control by neutrophil subsets. Blood Adv. (2018) 2:1344&#x2013;55. 10.1182/bloodadvances.2017015578</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2017015578</ArticleId><ArticleId IdType="pmc">PMC5998927</ArticleId><ArticleId IdType="pubmed">29895625</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillay J, Kamp VM, van Hoffen E, Visser T, Tak T, Lammers JW, et al. . A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest. (2012) 122:327&#x2013;36. 10.1172/JCI57990</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI57990</ArticleId><ArticleId IdType="pmc">PMC3248287</ArticleId><ArticleId IdType="pubmed">22156198</ArticleId></ArticleIdList></Reference><Reference><Citation>Peiseler M, Kubes P. More friend than foe: the emerging role of neutrophils in tissue repair. J Clin Invest. (2019) 129:2629&#x2013;39. 10.1172/JCI124616</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI124616</ArticleId><ArticleId IdType="pmc">PMC6597202</ArticleId><ArticleId IdType="pubmed">31205028</ArticleId></ArticleIdList></Reference><Reference><Citation>Marini O, Costa S, Bevilacqua D, Calzetti F, Tamassia N, Spina C, et al. . Mature CD10+ and immature CD10- neutrophils present in G-CSF-treated donors display opposite effects on T cells. Blood. (2017) 129:1343&#x2013;56. 10.1182/blood-2016-04-713206</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2016-04-713206</ArticleId><ArticleId IdType="pubmed">28053192</ArticleId></ArticleIdList></Reference><Reference><Citation>Luijk B, Lindemans CA, Kanters D, van der Heijde R, Bertics P, Lammers JWJ, et al. . Gradual increase in priming of human eosinophils during extravasation from peripheral blood to the airways in response to allergen challenge. J Allergy Clin Immunol. (2005) 115:997&#x2013;1003. 10.1016/j.jaci.2005.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2005.02.002</ArticleId><ArticleId IdType="pubmed">15867857</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson MW. Eosinophil activation status in separate compartments and association with asthma. Front Med. (2017) 4:75. 10.3389/fmed.2017.00075</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2017.00075</ArticleId><ArticleId IdType="pmc">PMC5466952</ArticleId><ArticleId IdType="pubmed">28660189</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Yang X, Wang H, Li Z, Deng H, Liu J, et al. . Analysis of the long-term impact on cellular immunity in COVID-19-recovered individuals reveals a profound NKT cell impairment. MBio. (2021) 12:e00085&#x2013;21. 10.1128/mBio.00085-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00085-21</ArticleId><ArticleId IdType="pmc">PMC8092197</ArticleId><ArticleId IdType="pubmed">33906918</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J. Neutrophils in tissue injury and repair. Cell Tissue Res. (2018) 371:531&#x2013;9. 10.1007/s00441-017-2785-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-017-2785-7</ArticleId><ArticleId IdType="pmc">PMC5820392</ArticleId><ArticleId IdType="pubmed">29383445</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindsley AW, Schwartz JT, Rothenberg ME. Eosinophil responses during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol. (2020) 146:1&#x2013;7. 10.1016/j.jaci.2020.04.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.04.021</ArticleId><ArticleId IdType="pmc">PMC7194727</ArticleId><ArticleId IdType="pubmed">32344056</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DM, Kim Y, Seo JW, Lee J, Park U, Ha NY, et al. . Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19. Cell Rep. (2021) 37:109798. 10.1016/j.celrep.2021.109798</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109798</ArticleId><ArticleId IdType="pmc">PMC8450316</ArticleId><ArticleId IdType="pubmed">34587481</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>